These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cartilage Oligomeric Matrix Protein promotes epithelial-mesenchymal transition by interacting with Transgelin in Colorectal Cancer. Zhong W; Hou H; Liu T; Su S; Xi X; Liao Y; Xie R; Jin G; Liu X; Zhu L; Zhang H; Song X; Yang C; Sun T; Cao H; Wang B Theranostics; 2020; 10(19):8790-8806. PubMed ID: 32754278 [No Abstract] [Full Text] [Related]
5. High Levels of Cartilage Oligomeric Matrix Protein in the Serum of Breast Cancer Patients Can Serve as an Independent Prognostic Marker. Papadakos KS; Darlix A; Jacot W; Blom AM Front Oncol; 2019; 9():1141. PubMed ID: 31737569 [No Abstract] [Full Text] [Related]
6. COMP Gene Coexpresses With EMT Genes and Is Associated With Poor Survival in Colon Cancer Patients. Nfonsam VN; Nfonsam LE; Chen D; Omesiete PN; Cruz A; Runyan RB; Jandova J J Surg Res; 2019 Jan; 233():297-303. PubMed ID: 30502262 [TBL] [Abstract][Full Text] [Related]
7. Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway. Liu TT; Liu XS; Zhang M; Liu XN; Zhu FX; Zhu FM; Ouyang SW; Li SB; Song CL; Sun HM; Lu S; Zhang Y; Lin J; Tang HM; Peng ZH J Cancer Res Clin Oncol; 2018 Jun; 144(6):1049-1063. PubMed ID: 29560517 [TBL] [Abstract][Full Text] [Related]
8. Cartilage oligomeric matrix protein in patients with osteoarthritis is independently associated with metastatic disease in prostate cancer. Rosas S; Hughes RT; Farris M; Lee H; McTyre ER; Plate JF; Shi L; Emory CL; Blackstock AW; Kerr BA; Willey JS Oncotarget; 2019 Jul; 10(46):4776-4785. PubMed ID: 31413818 [TBL] [Abstract][Full Text] [Related]
9. Increasing Incidence of Colon Cancer in the Young: Assessing the Tumor Biology. Nfonsam VN; Jecius H; Chen D; Omesiete PN; Ewongwo AN; Elquza E; Scott AJ; Jandova J J Am Coll Surg; 2019 Jul; 229(1):79-90. PubMed ID: 30995524 [TBL] [Abstract][Full Text] [Related]
11. Intracellular cartilage oligomeric matrix protein augments breast cancer resistance to chemotherapy. Hanitrarimalala V; Bednarska I; Murakami T; Papadakos KS; Blom AM Cell Death Dis; 2024 Jul; 15(7):480. PubMed ID: 38965233 [TBL] [Abstract][Full Text] [Related]
12. Stromal cartilage oligomeric matrix protein as a tumorigenic driver in ovarian cancer via Notch3 signaling and epithelial-to-mesenchymal transition. Gorji-Bahri G; Krishna BM; Hagerling C; Orimo A; Jirström K; Papadakos KS; Blom AM J Transl Med; 2024 Apr; 22(1):351. PubMed ID: 38615020 [TBL] [Abstract][Full Text] [Related]
13. The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma. Papadakos KS; Gorji-Bahri G; Gialeli C; Hedner C; Hagerling C; Svensson MC; Jeremiasen M; Borg D; Fristedt R; Jirström K; Blom AM Cancer Immunol Immunother; 2024 Apr; 73(5):93. PubMed ID: 38563861 [TBL] [Abstract][Full Text] [Related]
14. The molecular mechanism of thrombospondin family members in cardiovascular diseases. Pan H; Lu X; Ye D; Feng Y; Wan J; Ye J Front Cardiovasc Med; 2024; 11():1337586. PubMed ID: 38516004 [TBL] [Abstract][Full Text] [Related]
15. Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma. Ong KH; Hsieh YY; Lai HY; Sun DP; Chen TJ; Huang SK; Tian YF; Chou CL; Shiue YL; Wu HC; Chan TC; Tsai HH; Li CF; Su PA; Kuo YH Sci Rep; 2023 Oct; 13(1):17444. PubMed ID: 37838792 [TBL] [Abstract][Full Text] [Related]
16. COMP Improves Ang-II-Induced Atrial Fibrillation via TGF-β Signaling Pathway. Cai X; Li M; Zhong Y; Yang W; Liang Z Cardiovasc Toxicol; 2023 Oct; 23(9-10):305-316. PubMed ID: 37584842 [TBL] [Abstract][Full Text] [Related]
17. Novel gene signature for predicting biochemical recurrence-free survival of prostate cancer and PRAME modulates prostate cancer progression. Kadeerhan G; Xue B; Wu X; Hu X; Tian J; Wang D Am J Cancer Res; 2023; 13(7):2861-2877. PubMed ID: 37559989 [TBL] [Abstract][Full Text] [Related]
18. PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis. Lo Russo G; Prelaj A; Dolezal J; Beninato T; Agnelli L; Triulzi T; Fabbri A; Lorenzini D; Ferrara R; Brambilla M; Occhipinti M; Mazzeo L; Provenzano L; Spagnoletti A; Viscardi G; Sgambelluri F; Brich S; Miskovic V; Pedrocchi ALG; Trovo' F; Manglaviti S; Giani C; Ambrosini P; Leporati R; Franza A; McCulloch J; Torelli T; Anichini A; Mortarini R; Trinchieri G; Pruneri G; Torri V; De Braud F; Proto C; Ganzinelli M; Garassino MC J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37286305 [TBL] [Abstract][Full Text] [Related]
19. Expression of Cartilage Oligomeric Matrix Protein in colorectal cancer is an adverse prognostic factor and correlates negatively with infiltrating immune cells and PD-L1 expression. Blom AM; Gialeli C; Hagerling C; Berntsson J; Jirström K; Papadakos KS Front Immunol; 2023; 14():1167659. PubMed ID: 37207219 [TBL] [Abstract][Full Text] [Related]